|
| | Romurtide Basic information |
| Product Name: | Romurtide | | Synonyms: | l-lysine,n(sup2),(n(sup2)-(n-(n-acetylmuramoyl)-l-alanyl)-d-alpha-glutaminyl;ROMURTIDE;N-ACETYLMURAMYL-ALA-D-ISO-GLUTAMINYL-N-EPSILON-STEAROYL-LYS;MUROCTASIN;)-n(sup6)-(1-oxooctadecyl)-;dj-7041;Ac-muramyl-Ala-D-Glu(Lys(stearoyl)-OH)-NH;n(sup2)-((n-acetylmuramoyl)-l-alanyl-d-isoglutaminyl)-n(sup6)-stearoyl-l-ly | | CAS: | 78113-36-7 | | MF: | C43H78N6O13 | | MW: | 887.11 | | EINECS: | | | Product Categories: | Other Peptides;Peptides and Proteins;Peptides for Cell Biology | | Mol File: | 78113-36-7.mol |  |
| | Romurtide Chemical Properties |
| Melting point | 176-178° | | alpha | D20 +24.9° (c = 1 in methanol) | | Boiling point | 1220.7±65.0 °C(Predicted) | | density | 1.163±0.06 g/cm3(Predicted) | | storage temp. | −20°C | | pka | 5.70(at 25℃) |
| WGK Germany | 3 | | RTECS | OL5545000 | | Toxicity | LD50 in male, female mice, male, female rats, dogs (mg/kg): 436, 625, 761, 801, >200 s.c. (Ono) |
| | Romurtide Usage And Synthesis |
| Description | Romurtide is a muramyl dipeptide which augments the production of G-CSF. The
compound is indicated as an immunomodulator for the treatment of leukopenia caused
by anticancer chemotherapy/radiotherapy and also thrombopenia. | | Originator | Daiichi (Japan) | | Definition | ChEBI: Romurtide is an organic molecular entity. | | Brand name | Nopia |
| | Romurtide Preparation Products And Raw materials |
|
